To the content
1 . 2016

Insulin therapy of type 2 diabetes mellitus: effectiveness, safety and tolerability profile of Rinsulin R and Rinsulin NPH

Abstract

According to experts of the world Health organization, «diabetes – the epidemic is extremely complex by nature non-communicable diseases, often with tragic outcomes». The spread of diabetes mellitus (DM) worldwide is constantly increasing. Currently well studied the performance of different groups of antidiabetic drugs. The results of these studies, Rinsulin R and NPH have a good safety profile and tolerability, as well as convenient to use, which was noted by the patients. All these benefits together contribute to not only improve glycemia, but also increase competence in the treatment of patients with type 2 diabetes mellitus.

Keywords:type 2 diabetes mellitus, antihyperglycemic drugs, insulin therapy, glycemia, randomized patients, glycemic control

Endocrinology: News, Opinions, Training. 2016; (1): 81–87.

All articles in our journal are distributed under the Creative Commons Attribution 4.0 International License (CC BY 4.0 license)

CHIEF EDITOR
CHIEF EDITOR
Ametov Alexander S.
Honored Scientist of the Russian Federation, Doctor of Medical Sciences, Professor, Head of Subdepartment of Endocrinology, Head of the UNESCO Network Chair on the subject «Bioethics of diabetes as a global problem» of the Russian Medical Academy of Continuous Professional Education (Moscow)
Вскрытие

Journals of «GEOTAR-Media»